Clinical course of Japanese patients with early systemic sclerosis: A multicenter, prospective, observational study

Abstract

Objectives

To investigate the clinical course of Japanese patients with early diffuse cutaneous systemic sclerosis (dcSSc) and early SSc with interstitial lung disease (ILD).

Methods

We prospectively analyzed the clinical features of 207 Japanese patients with early dcSSc (n = 150) and limited cutaneous SSc (lcSSc) with ILD (n = 57) in 10 medical centers every year for 7 consecutive years.

Results

Mean modified Rodnan total skin thickness score (mRSS) was 18.3 and 67.4% of the cohort had ILD. Most patients started immunosuppressive therapy and vasodilators during 7 years (83.4% and 87.9%, respectively). Mean value of mRSS of total patients was significantly reduced from the initial registration after the first year. However, other parameters for physical function associated with skin sclerosis including fist closure, hand extension, and oral aperture were not so ameliorated during the study period. Health Assessment Questionnaire-disability index and serum KL-6 levels were constant throughout the course. Percent vital capacity and the presence of ILD, clinically suspected pulmonary arterial hypertension, and digital ulcers were gradually exacerbated during the period.

Conclusion

In Japanese early dcSSc patients and SSc patients with ILD, mRSS was continuously reduced during 7 years of follow-up, but there was little improvement of physical disability and organ involvement.

Keywords:

• Clinical course
• interstitial lung disease
• skin sclerosis
• systemic sclerosis
• treatment outcome

Acknowledgements

The manuscript has not been previously published nor has it been submitted simultaneously for publication elsewhere. The authors are grateful to all the participated patients and physicians who have contributed in assembling the data at each facility. The aythors also thank Tomoko Hayashi and Yuko Yamada (Department of Dermatology, Kanazawa University) for their assistance in registering data.

Conflict of interest

None.

Additional information

Funding

Financial support: This work was supported by funds for research on intractable diseases from the Ministry of Health, Labor, and Welfare of Japan.